- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pulmonary Hypertension Due to Lung Diseases and Hypoxia in United States
Total 3405 results
-
University of CambridgeMedical Research Council; British Heart FoundationRecruitingPulmonary Arterial HypertensionUnited Kingdom
-
Novartis PharmaceuticalsActive, not recruitingPulmonary Arterial HypertensionUnited States, Spain, Germany, Poland, United Kingdom, Netherlands, Argentina
-
Eli Lilly and CompanyCompletedPulmonary Arterial HypertensionUnited States, Spain, France, Poland, Canada, United Kingdom
-
Medtronic Cardiac Rhythm and Heart FailureUnited TherapeuticsActive, not recruitingPulmonary Arterial HypertensionUnited States
-
University of AlbertaImperial College LondonCompletedPulmonary Hypertension (Idiopathic, Familial or Anorexigen-associated)Canada, United Kingdom
-
Papworth Hospital NHS Foundation TrustRecruitingChronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
Francois HaddadPrecordior LtdActive, not recruitingHeart Failure | Pulmonary HypertensionUnited States
-
Pharmosa Biopharm Inc.PPDCompletedPulmonary Arterial HypertensionUnited States
-
Aires Pharmaceuticals, Inc.CompletedPulmonary Arterial HypertensionUnited States
-
ActelionTerminatedChronic Obstructive Pulmonary Disease | Pulmonary HypertensionUnited States, Spain, France
-
Epix Pharmaceuticals, Inc.CompletedChronic Obstructive Pulmonary Disease | Pulmonary HypertensionUnited States
-
Aridis Pharmaceuticals, Inc.CompletedPneumonia Due to Staphylococcus AureusUnited States, Belgium, France, Spain
-
University of California, San FranciscoRecruitingRight Ventricular Dysfunction | Pulmonary Artery HypertensionUnited States
-
Mannkind CorporationCompletedPulmonary Arterial HypertensionUnited States
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States
-
University of MinnesotaTerminatedPulmonary Hypertension | Cardiac MRI <40United States
-
International CTEPH AssociationCompletedChronic Thromboembolic Pulmonary Hypertension | CTEPHUnited States, Japan, Belgium, United Kingdom, Netherlands, Czechia, Germany, Austria, France, Poland
-
Liquidia Technologies, Inc.Nuventra, Inc.Active, not recruitingPrimary Pulmonary HypertensionUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustActelionCompletedPulmonary Artery HypertensionUnited Kingdom
-
Silverleaf Medical Sciences INCVA Loma Linda Health Care SystemNot yet recruitingHeart Failure | Pulmonary Arterial HypertensionUnited States
-
The University of QueenslandUniversity of Copenhagen; Erasmus Medical Center; Monash University; Hôpital Cochin and other collaboratorsRecruitingPulmonary Disease Due to Mycobacteria (Diagnosis)Australia, Canada, Denmark, France, Ireland, Netherlands, New Zealand, United Kingdom, Singapore
-
Brigham and Women's HospitalRecruitingPulmonary HypertensionUnited States
-
Vanderbilt University Medical CenterMayo Clinic; The Cleveland ClinicActive, not recruitingPulmonary Artery HypertensionUnited States
-
Insmed IncorporatedTerminatedPulmonary Arterial HypertensionUnited States
-
SoniVie Inc.Active, not recruitingPulmonary Arterial HypertensionUnited Kingdom, Israel, Belgium
-
Pulmonary Hypertension Association, Inc.University of Washington, the Collaborative Health Studies Coordinating CenterRecruitingPulmonary Arterial Hypertension | Pulmonary Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited States
-
National Health Service, United KingdomCompletedPulmonary Arterial HypertensionUnited Kingdom
-
University of MiamiCompleted
-
ActelionCompletedPulmonary Arterial Hypertension | Pulmonary Hypertension | Ayerza SyndromeUnited States
-
United TherapeuticsLung Biotechnology PBCCompletedPulmonary Arterial HypertensionUnited States
-
VA Loma Linda Health Care SystemActelionCompletedPulmonary Hypertension | AltitudeUnited States
-
Bastiaan DriehuysRecruitingPulmonary Arterial Hypertension | Interstitial Lung Disease | COPDUnited States
-
VentriPoint Diagnostics Ltd.CompletedPulmonary Arterial HypertensionUnited States, Canada
-
PhaseBio Pharmaceuticals Inc.TerminatedPulmonary Arterial HypertensionUnited States
-
Lung Biotechnology PBCCompletedPulmonary Arterial HypertensionUnited States, Belgium, Czechia, Germany, Ireland, Romania
-
United TherapeuticsCompletedPulmonary HypertensionUnited States
-
University of DundeeNHS Tayside; NHS Fife; Chief Scientist Office of the Scottish GovernmentCompletedChronic Obstructive Pulmonary Disease | Pulmonary HypertensionUnited Kingdom
-
Lung Biotechnology PBCCompletedPulmonary Arterial HypertensionUnited States, Belgium, Czechia, Germany, Ireland, Romania
-
University of AarhusMedical University of Vienna; KU Leuven; Amsterdam UMC, location VUmc; St. Antonius... and other collaboratorsRecruitingChronic Thromboembolic Pulmonary HypertensionDenmark, United Kingdom
-
Bial - Portela C S.A.CompletedPulmonary Arterial Hypertension | Cardiovascular Disease+Pulmonary DiseaseUnited Kingdom
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingHeart Failure | Pulmonary HypertensionUnited States
-
PfizerTerminatedPulmonary Arterial Hypertension | Pulmonary HypertensionUnited States, Bulgaria, Argentina, Chile, China, Colombia, Czech Republic, India, Malaysia, Mexico, Peru, Romania, Russian Federation, Serbia, South Africa, Thailand, Turkey, Ukraine
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; University of Cambridge; University of Newcastle Upon-Tyne and other collaboratorsRecruitingPulmonary Arterial HypertensionUnited Kingdom
-
Aerogen Pharma LimitedCompletedPulmonary HypertensionUnited States
-
University of Colorado, DenverCompletedPulmonary Hypertension | COPDUnited States
-
Gilead SciencesCompletedPulmonary HypertensionUnited States, Germany, Australia, Belgium, France, Italy
-
NXT BiomedicalEnrolling by invitation
-
Mayo ClinicActive, not recruiting
-
ActelionCompletedPulmonary HypertensionUnited States, Netherlands, Canada, Spain, China, Belgium, Germany, Italy, United Kingdom, Switzerland, Australia, Austria, Czech Republic, France
-
Papworth Hospital NHS Foundation TrustRoche Pharma AG; National Institute for Health Research, United KingdomCompletedPulmonary Arterial HypertensionUnited Kingdom